What do UK Rheumatologists do when the patient doesn't fit the guideline for treatment?

Rheumatology (Oxford). 2020 Jul 1;59(7):1465-1466. doi: 10.1093/rheumatology/keaa151.

Authors

David Walker¹, Bridget Griffiths², Patrick Kiely³, Helena Marzo-Ortega⁴

Affiliations

¹ Rheumatology, Northumbria Healthcare NHS Trust, North Shields.
² Rheumatology, Newcastle Healthcare NHS Trust, Newcastle.
³ St Georges Healthcare NHS Trust and Honorary Reader, Institute of Medical and Biomedical Education, St George's, University of London, London.
⁴ Leeds Institute for Rheumatic and Musculoskeletal Research, University of Leeds, Leeds, UK.

PMID: 32294218
DOI: 10.1093/rheumatology/keaa151

No abstract available

Publication types

Editorial

MeSH terms

Antirheumatic Agents / economics
Antirheumatic Agents / therapeutic use*
Cost-Benefit Analysis
Drug Approval
Health Policy*
Healthcare Financing
Humans
Practice Guidelines as Topic
Rheumatic Diseases / drug therapy*
Rheumatologists
State Medicine*
Technology Assessment, Biomedical
United Kingdom

Substances

Antirheumatic Agents